ESMO

green light go go ahead advance yes streetlight
Biotech

Moderna posts melanoma data behind decision to say 'I do' to IDO

Responses in melanoma patients failed by checkpoint inhibitors informed a decision to expand and prioritize development of the cancer candidate.
Nick Paul Taylor Oct 13, 2025 5:15am
artificial intelligence chip

ESMO: Owkin's deep learning AI predicts breast cancer relapse

Sep 22, 2021 10:25am
A 3D illustration of colon cancer

ESMO: Mirati pulls away from Amgen in colorectal cancer

Sep 19, 2021 9:47am
Office building showing Daiichi Sankyo logo

ESMO: Daiichi unveils first early peek at next-gen ADC

Sep 17, 2021 7:30am
Novartis

Novartis links cancer drug to improved pain, quality of life

Sep 16, 2021 6:05pm
Zymeworks

ESMO: Zymeworks lays down marker in fight to unseat Herceptin

Sep 16, 2021 8:50am